Compare Humana Inc (HUM) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Opendoor Technologies Inc — how do they compare? Humana Inc trades at $404.09 (market cap $47.81B), while Opendoor Technologies Inc trades at $4.42 (market cap $4.29B). The key difference: Humana Inc is far larger — about 11.1× Opendoor Technologies Inc's market cap, and Humana Inc pays a 0.89% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| HUM | OPEN | |
|---|---|---|
Market Cap | $47.81B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $409.42 | $10.52 |
52-Week Low | $163.67 | $1.84 |
Enterprise Value | $56.85B | $4.63B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Opendoor Technologies (OPEN) trades at $4.415, down 1.89% on the day, reflecting ongoing market skepticism despite recent operational improvements. The stock shows a bearish technical trend with mixed oscillators, while fundamentals reveal persistent losses with a -35.25% net income margin and negative ROE of -173.61%. Revenue has declined from $15.6B in 2022 to $4.37B in 2025, though cash flow turned positive in 2025 at $538M. Recent news highlights CEO focus on housing market challenges and India operations closure to prioritize AI integration.
The outlook remains cautious with high debt and profitability concerns offset by low P/S valuation and analyst 'Hold' consensus. Key risks include interest rate sensitivity and execution of the Opendoor 2.0 model, while potential upside hinges on margin stabilization and seasonal housing rebounds. Investors face a high-risk, speculative opportunity amid structural shifts in real estate tech.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
